4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001367644-21-000041
EVP, Chief Financial Officer gave up 1,829 shares (to pay taxes)
- EVP, Chief Financial Officer acquired 8,023 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
LINDAHL RICHARD S · EVP, Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-24 | Grant or award : show line 1 in the form | +4,011 | 35,790 | D | ||
| 2021-02-24 | Grant or award : show line 2 in the form | +4,012 | 39,802 | D | ||
| 2021-02-24 | Shares withheld for taxes : show line 3 in the form | −1,010 | $93.49 | $94,425 | 38,792 | D |
| 2021-02-26 | Shares withheld for taxes : show line 4 in the form | −819 | $97.15 | $79,566 | 37,973 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-24 | Grant or award : show line 5 in the form Employee Stock Options (Right to Buy) | +16,043 | $93.49 | $1,499,860 | 16,043 | D |
Loading xslF345X03/wf-form4_161437750812785.xml…